{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T22:31:14.702722+00:00","published_at":"2026-09-14T14:38:06.015003+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1yru8or1v6hj6r","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-24","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:craig-b-thompson-m-d","alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:e2334ab3c4149a293eb514cd02cd2e947ab3506779b9e2093b035bf7cc955cd7"],"summary":"Craig B. Thompson, M.D. executive of Apogee Therapeutics, Inc., effective 2026-04-24.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:10fdqmn96znkl","event_type":"CFO_CHANGED","effective_at":"2026-04-24","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:jane-pritchett-henderson-apge","alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:87156ef86c98e32b7bf461e46b081b137f9f7de3ac50bdd52b09c8d0ed15b83c"],"summary":"Jane Pritchett Henderson executive of Apogee Therapeutics, Inc., effective 2026-04-24.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:guie6rulca63","event_type":"CEO_CHANGED","effective_at":"2026-04-24","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:michael-henderson-m-d-apge","alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:9b1fea756f4ea1ab40890728da823247714aaedd9ec8dccedeb73e4ee2529cc7"],"summary":"Michael Henderson, M.D. executive of Apogee Therapeutics, Inc., effective 2026-04-24.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:3sx9b58bnuyb","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:lisa-bollinger-m-d","alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3"],"summary":"Lisa Bollinger, M.D. seat on Apogee Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:8iwe2018m2tyy","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:andrew-gottesdiener-m-d","alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3"],"summary":"Andrew Gottesdiener, M.D. seat on Apogee Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:388l4f1apxv9j","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:jennifer-fox","alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3"],"summary":"Jennifer Fox seat on Apogee Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:dcpr3d19u2mo1","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:mark-c-mckenna","alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3"],"summary":"Mark C. McKenna seat on Apogee Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:webg11185geu1","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:michael-henderson-m-d","alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3"],"summary":"Michael Henderson, M.D. seat on Apogee Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:qrt6w6m21zyc","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:nimish-shah","alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3"],"summary":"Nimish Shah seat on Apogee Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1q601tx193q3v3","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:peter-harwin","alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3"],"summary":"Peter Harwin seat on Apogee Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1p9iabs1bssue6","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:tomas-kiselak","alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3"],"summary":"Tomas Kiselak seat on Apogee Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1xztwbde3bpr9","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:william-bj-jones-jr","alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3"],"summary":"William (BJ) Jones, Jr. seat on Apogee Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:4v8q8y57wogy","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:peter-harwin","alpha:committee:apogee-therapeutics-inc:audit"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:committee_record:18"],"evidence_ids":["alpha:projection-evidence:5c021ef6e0a0c3361592857f9cada24aa9ba15ce9df7bd62022a82de4aee8b08"],"summary":"Peter Harwin member of Audit, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:2poo451801w0z","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:committee:apogee-therapeutics-inc:audit-chair-compensation","alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3"],"summary":"Audit · Chair; Compensation committee of Apogee Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:p9cvep44pzn3","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:jennifer-fox","alpha:committee:apogee-therapeutics-inc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3"],"summary":"Jennifer Fox member of Audit · Chair; Compensation, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:mucvqtnujlj1","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:committee:apogee-therapeutics-inc:compensation-chair","alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3"],"summary":"Compensation · Chair committee of Apogee Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1wx5lrd16uh44x","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:william-bj-jones-jr","alpha:committee:apogee-therapeutics-inc:compensation-chair"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3"],"summary":"William (BJ) Jones, Jr. member of Compensation · Chair, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:aanozf1q30r7h","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:committee:apogee-therapeutics-inc:compensation-nominating-and-governance-chair","alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3"],"summary":"Compensation; Nominating and Governance · Chair committee of Apogee Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:uau9k71ggqncz","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:mark-c-mckenna","alpha:committee:apogee-therapeutics-inc:compensation-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3"],"summary":"Mark C. McKenna member of Compensation; Nominating and Governance · Chair, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:zc9sqa1xufa6q","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-09-14T14:38:06.015003+00:00","subject_ids":["alpha:person:nimish-shah","alpha:committee:apogee-therapeutics-inc:nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:committee_record:25"],"evidence_ids":["alpha:projection-evidence:5c021ef6e0a0c3361592857f9cada24aa9ba15ce9df7bd62022a82de4aee8b08"],"summary":"Nimish Shah member of Nominating and Governance, effective 2023-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:6","subject_id":"alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:andrew-gottesdiener-m-d","object_label":"Andrew Gottesdiener, M.D.","object_source_name_forms":[],"value":"Andrew Gottesdiener, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:andrew-gottesdiener-m-d","name":"Andrew Gottesdiener, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-09-14T14:38:06.015003+00:00","sources":[{"id":"alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Apogee Therapeutics DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000095017025060147/apge-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:19:01.415+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-09-14T14:38:06.015003+00:00","reviewed_at":"2026-09-14T14:38:06.015003+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:7","subject_id":"alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jennifer-fox","object_label":"Jennifer Fox","object_source_name_forms":[],"value":"Jennifer Fox: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jennifer-fox","name":"Jennifer Fox"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-09-14T14:38:06.015003+00:00","sources":[{"id":"alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Apogee Therapeutics DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000095017025060147/apge-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:19:01.415+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-09-14T14:38:06.015003+00:00","reviewed_at":"2026-09-14T14:38:06.015003+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:8","subject_id":"alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:lisa-bollinger-m-d","object_label":"Lisa Bollinger, M.D.","object_source_name_forms":[],"value":"Lisa Bollinger, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:lisa-bollinger-m-d","name":"Lisa Bollinger, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-09-14T14:38:06.015003+00:00","sources":[{"id":"alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Apogee Therapeutics DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000095017025060147/apge-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:19:01.415+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-09-14T14:38:06.015003+00:00","reviewed_at":"2026-09-14T14:38:06.015003+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:9","subject_id":"alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:mark-c-mckenna","object_label":"Mark C. McKenna","object_source_name_forms":[],"value":"Mark C. McKenna: Director, Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:mark-c-mckenna","name":"Mark C. McKenna"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-09-14T14:38:06.015003+00:00","sources":[{"id":"alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Apogee Therapeutics DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000095017025060147/apge-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:19:01.415+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-09-14T14:38:06.015003+00:00","reviewed_at":"2026-09-14T14:38:06.015003+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:10","subject_id":"alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-henderson-m-d","object_label":"Michael Henderson, M.D.","object_source_name_forms":[],"value":"Michael Henderson, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-henderson-m-d","name":"Michael Henderson, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-09-14T14:38:06.015003+00:00","sources":[{"id":"alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Apogee Therapeutics DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000095017025060147/apge-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:19:01.415+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-09-14T14:38:06.015003+00:00","reviewed_at":"2026-09-14T14:38:06.015003+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:11","subject_id":"alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:nimish-shah","object_label":"Nimish Shah","object_source_name_forms":[],"value":"Nimish Shah: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:nimish-shah","name":"Nimish Shah"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-09-14T14:38:06.015003+00:00","sources":[{"id":"alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Apogee Therapeutics DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000095017025060147/apge-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:19:01.415+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-09-14T14:38:06.015003+00:00","reviewed_at":"2026-09-14T14:38:06.015003+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:12","subject_id":"alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:peter-harwin","object_label":"Peter Harwin","object_source_name_forms":[],"value":"Peter Harwin: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:peter-harwin","name":"Peter Harwin"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-09-14T14:38:06.015003+00:00","sources":[{"id":"alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Apogee Therapeutics DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000095017025060147/apge-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:19:01.415+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-09-14T14:38:06.015003+00:00","reviewed_at":"2026-09-14T14:38:06.015003+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:13","subject_id":"alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:tomas-kiselak","object_label":"Tomas Kiselak","object_source_name_forms":[],"value":"Tomas Kiselak: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:tomas-kiselak","name":"Tomas Kiselak"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-09-14T14:38:06.015003+00:00","sources":[{"id":"alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Apogee Therapeutics DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000095017025060147/apge-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:19:01.415+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-09-14T14:38:06.015003+00:00","reviewed_at":"2026-09-14T14:38:06.015003+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:14","subject_id":"alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:william-bj-jones-jr","object_label":"William (BJ) Jones, Jr.","object_source_name_forms":[],"value":"William (BJ) Jones, Jr.: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:william-bj-jones-jr","name":"William (BJ) Jones, Jr."},"title":"Director","role_category":"director","committee":"Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-09-14T14:38:06.015003+00:00","sources":[{"id":"alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Apogee Therapeutics DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000095017025060147/apge-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:19:01.415+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-09-14T14:38:06.015003+00:00","reviewed_at":"2026-09-14T14:38:06.015003+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:15","subject_id":"alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:craig-b-thompson-m-d","object_label":"Craig B. Thompson, M.D.","object_source_name_forms":[],"value":"Craig B. Thompson, M.D.: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:craig-b-thompson-m-d","name":"Craig B. Thompson, M.D."},"title":"Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-24","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-24","valid_to":null,"recorded_at":"2026-09-14T14:38:06.015003+00:00","sources":[{"id":"alpha:projection-evidence:document:e2334ab3c4149a293eb514cd02cd2e947ab3506779b9e2093b035bf7cc955cd7","identity_scope":"source_document_reference","source_type":"sec_filing","title":"APGE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526177342/apge-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-05-14T23:32:07.599947+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24T00:00:00+00:00","effective_from":"2026-04-24","effective_until":null,"observed_at":"2026-09-14T14:38:06.015003+00:00","reviewed_at":"2026-09-14T14:38:06.015003+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:16","subject_id":"alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jane-pritchett-henderson-apge","object_label":"Jane Pritchett Henderson","object_source_name_forms":[],"value":"Jane Pritchett Henderson: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jane-pritchett-henderson-apge","name":"Jane Pritchett Henderson"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-24","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-24","valid_to":null,"recorded_at":"2026-09-14T14:38:06.015003+00:00","sources":[{"id":"alpha:projection-evidence:document:87156ef86c98e32b7bf461e46b081b137f9f7de3ac50bdd52b09c8d0ed15b83c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"APGE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526177342/apge-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-05-14T23:32:08.017596+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24T00:00:00+00:00","effective_from":"2026-04-24","effective_until":null,"observed_at":"2026-09-14T14:38:06.015003+00:00","reviewed_at":"2026-09-14T14:38:06.015003+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:17","subject_id":"alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:michael-henderson-m-d-apge","object_label":"Michael Henderson, M.D.","object_source_name_forms":[],"value":"Michael Henderson, M.D.: Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:michael-henderson-m-d-apge","name":"Michael Henderson, M.D."},"title":"Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-24","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-24","valid_to":null,"recorded_at":"2026-09-14T14:38:06.015003+00:00","sources":[{"id":"alpha:projection-evidence:document:9b1fea756f4ea1ab40890728da823247714aaedd9ec8dccedeb73e4ee2529cc7","identity_scope":"source_document_reference","source_type":"sec_filing","title":"APGE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526177342/apge-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-05-14T23:32:07.154839+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-24T00:00:00+00:00","effective_from":"2026-04-24","effective_until":null,"observed_at":"2026-09-14T14:38:06.015003+00:00","reviewed_at":"2026-09-14T14:38:06.015003+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:committee_record:18","subject_id":"alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Jennifer Fox; Members Jennifer Fox (Chair); Peter Harwin","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Jennifer Fox","members":[{"display_name":"Jennifer Fox","person_slug":"jennifer-fox","is_chair":true},{"display_name":"Peter Harwin","person_slug":"peter-harwin","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-14T14:38:06.015003+00:00","sources":[{"id":"alpha:projection-evidence:5c021ef6e0a0c3361592857f9cada24aa9ba15ce9df7bd62022a82de4aee8b08","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1974640/000095017025060147/apge-20250429.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-14T14:38:06.015003+00:00","reviewed_at":"2026-09-14T14:38:06.015003+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:committee_record:25","subject_id":"alpha:company:72e207ff-72da-40c0-aca0-8b01c08b6b8a","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Mark C. McKenna; Members Mark C. McKenna (Chair); Nimish Shah","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Mark C. McKenna","members":[{"display_name":"Mark C. McKenna","person_slug":"mark-c-mckenna","is_chair":true},{"display_name":"Nimish Shah","person_slug":"nimish-shah","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-09-14T14:38:06.015003+00:00","sources":[{"id":"alpha:projection-evidence:5c021ef6e0a0c3361592857f9cada24aa9ba15ce9df7bd62022a82de4aee8b08","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1974640/000095017025060147/apge-20250429.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-09-14T14:38:06.015003+00:00","reviewed_at":"2026-09-14T14:38:06.015003+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:6edf7083a057288bdd132b99ce52f0c3b8f349a0e1225b43e8688bbdabd81fc3","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Apogee Therapeutics DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000095017025060147/apge-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-24T16:19:01.415+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:e2334ab3c4149a293eb514cd02cd2e947ab3506779b9e2093b035bf7cc955cd7","identity_scope":"source_document_reference","source_type":"sec_filing","title":"APGE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526177342/apge-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-05-14T23:32:07.599947+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:87156ef86c98e32b7bf461e46b081b137f9f7de3ac50bdd52b09c8d0ed15b83c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"APGE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526177342/apge-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-05-14T23:32:08.017596+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:9b1fea756f4ea1ab40890728da823247714aaedd9ec8dccedeb73e4ee2529cc7","identity_scope":"source_document_reference","source_type":"sec_filing","title":"APGE DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1974640/000119312526177342/apge-20260424.htm","source_date":"2026-04-24T00:00:00+00:00","retrieved_at":"2026-05-14T23:32:07.154839+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:5c021ef6e0a0c3361592857f9cada24aa9ba15ce9df7bd62022a82de4aee8b08","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1974640/000095017025060147/apge-20250429.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.824,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":0.9,"evidence_completeness":1,"source_authority":0.88,"cross_source_agreement":0.75,"temporal_completeness":0.632},"diagnostics":{"published_claims":27,"factual_claims":27,"claims_with_linked_evidence":27,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":19,"temporal_claims_with_valid_from":12,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-09-14T14:38:06.015003+00:00","observed_at":"2026-09-14T14:38:06.015003+00:00","reviewed_at":"2026-09-14T14:38:06.015003+00:00","verified_at":"2026-09-14T14:38:06.015003+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":27,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/apogee-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/apogee-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}